NEW YORK— The federal government says health care facilities should stop using Hospira's Symbiq medication infusion pump because of its vulnerability to hacking. The FDA says the computerized pumps could be accessed remotely through a hospital's network, but it doesn't know of any cases where that has happened. Earlier this year the FDA and the Homeland...» Read More
Apple's online store lists a lot of fitness-related products, but don't look for Fitbit.
Robots are joining doctors and scientists in combating the deadly Ebola outbreak.
Want to know what's giving health stocks confidence in profit forecasts? Like it or not, it's the Affordable Care Act, aka Obamacare.
Health care has been on a tear in 2014, and there is still room for upside. Wall Street analysts are focusing on the following four trends.
The first trial of an Ebola vaccine has started with the vaccination of three health care workers in Mali, researchers told NBC News.
The company aims to make the apps available by the end of the month.
The founder of Consumer Physics pitched his SCiO product, a molecular hand-held scanner that aims to be your sixth sense. Can he convince the panel?
A hedge fund manager is the latest to embark on one of the most ancient of human quests: immortality.
Lawrence Livermore is reaching out to private industry amid a race for talent and ideas to solve pressing issues including national security.
Here's the problem with a recent attempt by the government to make health costs more transparent, says the CEO of Change Healthcare.
An unconventional but effective treatment against a deadly superbug is raising worries about a possible black market.
CNBC's Meg Tirrell reports the pharmaceutical company has developed a new drug that significantly improves lung function in the treatment of cystic fibrosis.
ZocDoc is the new king of New York start-ups.
WebMD will launch Healthy Target, a service that collects data from wearables to offer up personalized health content and tips.
Data released shows weaker health care spending in the US.
A possible White House move to bail out insurance companies would be a slip toward government domination of health care, Athenahealth CEO Jonathan Bush says.
Nevada's health-care exchange is cutting ties with Xerox and will partner with the federal system for 2015, the Las Vegas Review Journal reported.
U.S. medical firm Allergan rejected the unsolicited takeover offer from Valeant Pharmaceuticals, saying it substantially undervalued the company.
Boston Scientific received a subpoena this week from the Department of Health and Human Services seeking information about its defibrillators.
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.